Our mission is to equip our health care partners with the best possible solutions, enabling them to deliver quality care, improve population health management and increase efficiency.
GREENWICH, CT and JACKSONVILLE, FL (PRWEB) April 14, 2015
Great Point Partners (“GPP”) today announced that Dr. Barry M Straube, M.D., formerly the Chief Medical Officer of CMS (Center for Medicare and Medicaid Services), has agreed to join the Board of Directors of its GPP II portfolio company Citra Health Solutions (“Citra”). The Jacksonville-based company provides tools and services that allow the health care industry to succeed in the emerging value-based environment and in the growth of ACO’s (“Accountable Care Organizations”).
“Our mission is to equip our health care partners with the best possible solutions, enabling them to deliver quality care, improve population health management and increase efficiency,” said Howard Buff, Chief Executive Officer at Citra. “With the exciting addition of Dr. Straube to our board, we take another important step in building a team that is capable of fulfilling these ambitions. Dr. Straube’s impressive track record will validate and further enhance the value of our programs.”
Dr. Straube brings to Citra extensive physician executive and clinical leadership experience in the physician-hospital, managed care, technology & innovation and federal/state health care sectors. Previously, he served as Chief Medical Officer for CMS for six years as well as the Director of the CMS Office of Clinical Standards & Quality (OCSQ). He currently serves as Director with The Marwood Group, a health care advisory and financial services firm headquartered in New York City.
Prior to his government service, Dr. Straube served in a number of senior physician management positions for Foundation Health Systems and Health Net, where he held the roles of Vice President, Quality Improvement and Senior Medical Director.
Dr. Straube received an A.B. magna cum laude and Phi Beta Kappa from Princeton University and an M.D. from the University of Michigan Medical School.
“Citra has had record quarterly sales and we welcome the immediate contributions that Dr. Straube can make to the Company’s value-based programs,” added Adam Dolder of Great Point Partners.
About Citra Health Solutions
Citra Health Solutions (“Citra”) aligns the needs of providers and patients with a focus on better health and more efficient value-based management. By combining scalable services with technical solutions, Citra enables its partner to optimize business practices while improving health outcomes for patients. Visit http://www.citrahealth.com for additional information.
About Great Point Partners
Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with approximately $800 million of equity capital under management and 26 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new private equity investments from GPP II, which has closed on $215 million. Great Point manages capital in private (GPP I, $156 million, and GPP II) and public (BMVF, approximately $370 million) equity funds. Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 health care companies. The private equity funds invest across all sectors of the health care industry with particular emphasis on biopharmaceutical infrastructure, devices and diagnostics, health care services, outsourcing, and information technology. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at 203-971-3300 or http://www.gppfunds.com